Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report)’s share price traded down 2.1% during trading on Wednesday. The stock traded as low as $61.00 and last traded at $61.51. Approximately 331,800 shares were traded during mid-day trading, an increase of 445% from the average daily volume of 60,916 shares. The stock had previously closed at $62.8350.
Eisai Stock Performance
The firm has a 50 day moving average of $61.51 and a 200-day moving average of $61.51. The stock has a market capitalization of $17.64 billion, a PE ratio of 70.70, a P/E/G ratio of 2.46 and a beta of 0.31. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.77 and a current ratio of 2.20.
About Eisai
Eisai is a Japan-based pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its research and commercial activities focus primarily on neurology and oncology, alongside other therapeutic areas. The company’s medicines include lecanemab, marketed as Leqembi for Alzheimer’s disease in certain markets, and lenvatinib, marketed as Lenvima for several types of cancer. Eisai also offers treatments for conditions including insomnia, epilepsy and cancer. Founded in Japan in 1941, Eisai serves patients and healthcare providers in Japan and other markets around the world.
Further Reading
- Five stocks we like better than Eisai
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
